GCP
EVH icon

GSA Capital Partners’s Evolent Health EVH Stock Holding History

GSA Capital Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
561,189
+248,530
+79% +$953K 0.19% 60
2026
Q1 		$713K Buy
312,659
+4,510
+1% +$14.3K 0.04% 687
2025
Q4 		$1.23M Buy
308,149
+291,173
+1,715% +$1.62M 0.11% 254
2025
Q3 		$144K Buy
+16,976
New +$165K 0.01% 1485
2025
Q1 		– Sell
-40,370
Closed -$454K – 1772
2024
Q4 		$454K Buy
+40,370
New +$709K 0.03% 965
2024
Q2 		– Sell
-6,654
Closed -$218K – 1737
2024
Q1 		$218K Buy
+6,654
New +$212K 0.02% 1373
2022
Q2 		– Sell
-16,873
Closed -$545K – 1505
2022
Q1 		$545K Buy
+16,873
New +$442K 0.07% 469
2021
Q1 		– Sell
-15,690
Closed -$252K – 1214
2020
Q4 		$252K Sell
15,690
-75,210
-83% -$994K 0.04% 840
2020
Q3 		$1.13M Buy
+90,900
New +$1.07M 0.19% 81
2020
Q2 		– Sell
-37,652
Closed -$204K – 746
2020
Q1 		$204K Buy
+37,652
New +$336K 0.05% 748
2019
Q3 		– Sell
-32,374
Closed -$257K – 1482
2019
Q2 		$257K Buy
+32,374
New +$383K 0.03% 1097
2017
Q2 		– Sell
-21,900
Closed -$488K – 1744
2017
Q1 		$488K Buy
+21,900
New +$420K 0.03% 1112

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

GSA Capital Partners's EVH Position: Q2 2026 in Review

GSA Capital Partners increased its Evolent Health (EVH) stake by 79% in Q2 2026, buying an estimated $953K and bringing the position to 561,189 shares worth $3.04M. The position accounts for 0.19% of the portfolio, ranked #60.

GSA Capital Partners first reported a position in EVH in Q1 2017 and has held it in 12 quarters since. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • GSA Capital Partners held 561,189 shares of Evolent Health worth $3.04M as of Q2 2026.
  • GSA Capital Partners bought 248,530 Evolent Health shares in Q2 2026, an estimated $953K.
  • Evolent Health made up 0.19% of GSA Capital Partners's portfolio in Q2 2026, its #60 holding.
  • GSA Capital Partners first reported a position in Evolent Health in Q1 2017 and has held it in 12 quarters since.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.